000 01023 a2200313 4500
005 20250513085556.0
264 0 _c19960417
008 199604s 0 0 eng d
022 _a0959-8138
024 7 _a10.1136/bmj.312.7031.591
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKristiansen, B E
245 0 0 _aSecondary prevention of meningococcal disease.
_h[electronic resource]
260 _bBMJ (Clinical research ed.)
_cMar 1996
300 _a591-2 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aHumans
650 0 4 _aMeningitis, Meningococcal
_xprevention & control
650 0 4 _aPenicillins
_xtherapeutic use
650 0 4 _aRifampin
_xtherapeutic use
650 0 4 _aRisk Factors
700 1 _aKnapskog, A B
773 0 _tBMJ (Clinical research ed.)
_gvol. 312
_gno. 7031
_gp. 591-2
856 4 0 _uhttps://doi.org/10.1136/bmj.312.7031.591
_zAvailable from publisher's website
999 _c8594370
_d8594370